MPH Health Care AG (93M1) AI Stock Analysis

6 Followers

MPH Health Care AG

(XETRA:93M1)

Select Model

Rating:74Outperform

Price Target:EUR 33.00▲(6.45% Upside)

Action:reiterated

Date:09/06/26

The overall stock score is buoyed by deeply attractive valuation metrics and a strong technical uptrend, underpinned by a highly stable, low-leverage balance sheet. However, significant weaknesses in cash generation and earnings quality weigh heavily on the underlying fundamentals, capping the upside potential.

Positive Factors

Conservative balance sheetDebt-to-equity of roughly 2%-6% across periods indicates limited balance-sheet leverage and meaningful financial flexibility. That conservative funding profile can help MPH absorb volatility in portfolio values and preserve capacity to manage or develop healthcare investments over the next several quarters.

Negative Factors

Highly erratic revenueHighly erratic revenue, including a reported 62.4% decline in revenue growth, makes the company’s earnings trajectory difficult to forecast. Even with recent profitability, unstable top-line results can weaken confidence in recurring performance and complicate long-term capital allocation.

MPH Health Care AG (93M1) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 132.72M
Dividend Yield: 16.13%
Average Volume (3M): 2,028
Price to Earnings (P/E): 1.2
Beta (1Y): 0.67
Revenue Growth: -62.35%
EPS Growth: ―
Country: Germany
Employees: 2
Sector: Financial
Sector Strength: 68
Industry: Asset Management

MPH Health Care AG Business Overview & Revenue Model

Company Description

MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and vario...

How the Company Makes Money

MPH Health Care AG primarily makes money through its role as a holding company that owns stakes in healthcare-related businesses. Its earnings are typically generated from (1) dividends and profit distributions received from portfolio companies (when...

MPH Health Care AG Financial Statement Overview

Summary

The company presents a mixed financial profile. While it boasts a pristine balance sheet with negligible debt and a solid equity base, this is heavily offset by poor earnings quality and alarmingly weak operating cash flow conversion.

Income Statement

65Positive

Balance Sheet

90Very Positive

Cash Flow

30Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	358.93M	364.30M	6.11M	7.24M	6.85M	4.36M
Gross Profit	358.90M	364.30M	6.11M	125.94M	6.80M	4.01M
EBITDA	112.79M	34.10M	33.32M	30.36M	29.68M	-9.05M
Net Income	107.05M	29.30M	32.04M	29.54M	29.11M	-8.96M
Balance Sheet
Total Assets	266.68M	258.09M	291.06M	266.35M	236.99M	198.00M
Cash, Cash Equivalents and Short-Term Investments	2.82M	1.37M	1.20M	5.10M	3.82M	4.44M
Total Debt	15.37M	11.63M	10.56M	13.05M	12.99M	4.05M
Total Liabilities	18.27M	14.68M	13.19M	15.39M	15.57M	5.69M
Stockholders Equity	248.41M	243.41M	277.87M	250.97M	221.42M	192.31M
Cash Flow
Free Cash Flow	0	123.01K	1.83M	-2.02M	-170.41K	-1.28M
Operating Cash Flow	11.02M	130.88K	1.83M	-2.02M	-164.79K	-1.28M
Investing Cash Flow	-3.79M	-3.29M	3.40M	5.40M	-8.96M	6.37M
Financing Cash Flow	-11.85M	-6.85M	-7.70M	7.74M	-3.02M	-3.61M

MPH Health Care AG Technical Analysis

Technical Analysis SentimentPositive

Last Price31.00

Price Trends

50DMA27.63Positive

100DMA25.98Positive

200DMA22.33Positive

Market Momentum

MACD0.70Negative

RSI70.11Negative

STOCH74.07Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:93M1, the sentiment is Positive. The current price of 31.00 is above the 20-day moving average (MA) of 28.63, above the 50-day MA of 27.63, and above the 200-day MA of 22.33, indicating a bullish trend. The MACD of 0.70 indicates Negative momentum. The RSI at 70.11 is Negative, neither overbought nor oversold. The STOCH value of 74.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:93M1.

MPH Health Care AG Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

DE:93M1 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:93M1	74Outperform	EUR 124.59M	1.24	43.53%	16.13%	-62.35%	―
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
DE:DMP	65Neutral	EUR 1.91B	12.62	22.38%	2.52%	0.39%	38.58%
DE:B8FK	53Neutral	EUR 18.29M	-1.54	-127.78%	―	―	―
DE:EVT	50Neutral	EUR 561.41M	-3.07	-25.63%	―	-5.03%	-13.63%

* Financial Sector Average

Performance Comparison

DE:93M1 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:93M1	MPH Health Care AG	31.00	15.05	94.32%
DE:B8FK	Biofrontera AG	3.00	0.33	12.36%
DE:EVT	Evotec AG (UK)	3.12	-2.17	-40.95%
DE:PA8	PAION AG	0.05	0.03	283.33%
DE:DMP	Dermapharm Holding	34.95	1.19	3.51%
DE:SBX	SynBiotic SE	0.12	-2.08	-94.36%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026

MPH Health Care AG AI Stock Analysis